Work

Supplementary Figure 2 from CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma

Year: 2023
Type: supplementary-materials
Abstract: PDF file, 2191K, Silencing of CSPG4 expression in MM cells.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361909920
Cites:
Cited by:
Related to: 10